Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sitronics Group plans to create a high-speed electric vessel for intercity transportation

10/12/23 AFKS

OGK-2's output for 9 months of 2023 increased by 7.5%

10/12/23 OGKB

Pyatyorochka launched a distribution center in the Orenburg region

10/12/23 FIVE

Alfa Bank replaced Veb Ventures in the TEA Next project

10/12/23 RTKM

Chelyabinsk Metallurgical Plant reported for 9 months of 2023 by RAS

10/12/23 CHMK

Delta Air Lines reported for 9 months of 2023

10/12/23 DAL

Ural Forge reported for 9 months of 2023 by RAS

10/12/23 URKZ

SPB Exchange ready to launch Bitcoin trading, if permitted

10/12/23 SPBE

Magnit will install more than 10 thousand self-service cash desks

10/12/23 MGNT

Moscow Exchange proposes to make a blockchain-based depository for BRICS countries

10/12/23 MOEX